Skip to main content
SpringerLink
Log in

Clinical significance of fractional magnesium excretion (FEMg) as a predictor of interstitial nephropathy and its correlation with conventional parameters

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

Elevated urine Mg excretion and its correlation with histological damage in tubulo-interstitial nephropathy (TIN) were reported. Here we investigated the clinical significance of the fractional excretion of Mg (FEMg) for the prediction of TIN.

Methods

We enrolled and assessed 94 adult patients with various renal diseases diagnosed principally by renal biopsy.

Results

Our stratified analysis based on the value of the conventional TIN parameter N-acetylglucosaminidase (NAG) excretion showed that the high-NAG index group (more than median value of NAG-to-Cr ratio, n = 47) demonstrated significantly high FEMg values (p = 0.017). A univariate analysis revealed a significant correlation between the FEMg and the NAG index (R = 0.60) but not for other parameters. A multivariate regression analysis confirmed the significance of the FEMg as an effective predictor of the NAG index. The FEMg showed a significant correlation with the estimated glomerular filtration rate (eGFR) in the patients with eGFR ≤ 30 mL/min. The correlation of FEMg with the NAG index was not observed in the primary glomerulonephritis patients but was apparent in the patients with hypertensive nephrosclerosis or interstitial nephritis.

Conclusion

Our findings may indicate that the combination of the FEMg and the NAG index can provide a specific, sensitive assessment for TIN in patients without renal insufficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Mackensen-Haen S, Bader R, Grund KE, Bohle A. Correlations between renal cortical interstitial fibrosis, atrophy of the proximal tubules and impairment of the glomerular filtration rate. Clin Nephrol. 1981;15:167–71.

    CAS  PubMed  Google Scholar 

  2. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis. 1992;20:1–17.

    Article  CAS  PubMed  Google Scholar 

  3. Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J. Tubulointerstitial damage and progression of renal failure. Kidney Int Suppl. 2005;99:S82–6.

    Article  CAS  PubMed  Google Scholar 

  4. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int. 1999;56:1627–37.

    Article  CAS  PubMed  Google Scholar 

  5. Donadio C. Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary beta-trace protein. Am J Physiol Renal Physiol. 2010;299:F1407–23.

    Article  CAS  PubMed  Google Scholar 

  6. Morii T, Fujita H, Narita T, Koshimura J, Shimotomai T, Fujishima H, Yoshioka N, Imai H, Kakei M, Ito S. Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases. Ren Fail. 2003;25:439–44.

    Article  CAS  PubMed  Google Scholar 

  7. Braden GL, Germain MJ, Fitzgibbons JP. Impaired potassium and magnesium homeostasis in acute tubulo-interstitial nephritis. Nephron. 1985;41:273–8.

    Article  CAS  PubMed  Google Scholar 

  8. Futrakul P, Yenrudi S, Futrakul N, Sensirivatana R, Kingwatanakul P, Jungthirapanich J, Cherdkiadtikul T, Laohapaibul A, Watana D, Singkhwa V, Futrakul S, Pongsin P. Tubular function and tubulointerstitial disease. Am J Kidney Dis. 1999;33:886–91.

    Article  CAS  PubMed  Google Scholar 

  9. Miura K, Nakatani T, Asai T, Yamanaka S, Tamada S, Tashiro K, Kim S, Okamura M, Iwao H. Role of hypomagnesemia in chronic cyclosporine nephropathy. Transplantation. 2002;73:340–7.

    Article  CAS  PubMed  Google Scholar 

  10. Deekajorndech T. A biomarker for detecting early tubulointerstitial disease and ischemia in glomerulonephropathy. Ren Fail. 2007;29:1013–7.

    Article  CAS  PubMed  Google Scholar 

  11. Khositseth S, Sudjaritjan N, Tananchai P, Ong-ajyuth S, Sitprija V, Thongboonkerd V. Renal magnesium wasting and tubular dysfunction in leptospirosis. Nephrol Dial Transplant. 2008;23:952–8.

    Article  CAS  PubMed  Google Scholar 

  12. Kim YK, Song HC, Kim WY, Yoon HE, Choi YJ, Ki CS, Park CW, Yang CW, Kim J, Kim YS, Choi EJ, Bang BK. Acquired Gitelman syndrome in a patient with primary Sjogren syndrome. Am J Kidney Dis. 2008;52:1163–7.

    Article  CAS  PubMed  Google Scholar 

  13. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H. The Japanese Society of Hypertension Guidelines for the management of hypertension (JSH 2009). Hypertens Res. 2009;32:3–107.

    Article  CAS  PubMed  Google Scholar 

  14. Glaudemans B, Knoers NV, Hoenderop JG, Bindels RJ. New molecular players facilitating Mg(2+) reabsorption in the distal convoluted tubule. Kidney Int. 2010;77:17–22.

    Article  CAS  PubMed  Google Scholar 

  15. Abraham P, Indirani K, Sugumar E. Effect of cyclophosphamide treatment on selected lysosomal enzymes in the kidney of rats. Exp Toxicol Pathol. 2007;59:143–9.

    Article  CAS  PubMed  Google Scholar 

  16. Morii T, Fujita H, Narita T, Shimotomai T, Fujishima H, Yoshioka N, Imai H, Kakei M, Ito S. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. J Diabetes Complicat. 2003;17:11–5.

    Article  PubMed  Google Scholar 

  17. Foster JE, Harpur ES, Garland HO. An investigation of the acute effect of gentamicin on the renal handling of electrolytes in the rat. J Pharmacol Exp Ther. 1992;261:38–43.

    CAS  PubMed  Google Scholar 

  18. Nijenhuis T, Hoenderop JG, Bindels RJ. Downregulation of Ca(2+) and Mg(2+) transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia. J Am Soc Nephrol. 2004;15:549–57.

    Article  CAS  PubMed  Google Scholar 

  19. Ettinger LJ, Gaynon PS, Krailo MD, Ru N, Baum ES, Siegel SE, Hammond GD. A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer Group. Cancer. 1994;73:1297–301.

    Article  CAS  PubMed  Google Scholar 

  20. Shah GM, Kirschenbaum MA. Renal magnesium wasting associated with therapeutic agents. Miner Electrolyte Metab. 1991;17:58–64.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Financial Supporting Project for young investigators at Saitama Medical Center, Saitama Medical University (#24-C-1-C08), and was also supported, in part, by research grants from the Research Foundation for Community Medicine, Utsunomiya, Tochigi, Japan. We gratefully acknowledge Mr. T. Ozawa for his technical assistance.

Conflict of interest

The authors state that they have no conflicts of interest to disclose.

Author information

Authors and Affiliations

  1. Department of Nephrology and Hypertension, Saitama Medical Center, Saitama Medical University, Kamoda 1981, Kawagoe, Saitama, 350-8550, Japan

    Chie Noiri, Taisuke Shimizu, Kaori Takayanagi, Yosuke Tayama, Takatsugu Iwashita, Shimpei Okazaki, Minoru Hatano, Osamu Matsumura, Hitoshi Kato, Akihiko Matsuda, Tetsuya Mitarai & Hajime Hasegawa

  2. Ishikawa Kinenkai Kawagoe Ekimae Clinic, Wakita-honmachi16-23, Kawagoe, Saitama, 350-1123, Japan

    Kaori Takayanagi

Authors
  1. Chie Noiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Taisuke Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kaori Takayanagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yosuke Tayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takatsugu Iwashita
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shimpei Okazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Minoru Hatano
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Osamu Matsumura
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hitoshi Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Akihiko Matsuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Tetsuya Mitarai
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Hajime Hasegawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hajime Hasegawa.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Noiri, C., Shimizu, T., Takayanagi, K. et al. Clinical significance of fractional magnesium excretion (FEMg) as a predictor of interstitial nephropathy and its correlation with conventional parameters. Clin Exp Nephrol 19, 1071–1078 (2015). https://doi.org/10.1007/s10157-015-1099-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-015-1099-x

Keywords

Search

Navigation